CTP synthetase

Last updated
CTP synthase
1s1m.jpg
Identifiers
EC no. 6.3.4.2
CAS no. 9023-56-7
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / QuickGO
Search
PMC articles
PubMed articles
NCBI proteins

CTP synthase is an enzyme (EC 6.3.4.2) involved in pyrimidine biosynthesis that interconverts UTP and CTP. [1] [2]

Contents

Reaction mechanism

CTP (cytidine triphosphate) synthetase catalyzes the last committed step in pyrimidine nucleotide biosynthesis: [3]

ATP + UTP + glutamine → ADP + Pi + CTP + glutamate

It is the rate-limiting enzyme for the synthesis of cytosine nucleotides from both the de novo and uridine salvage pathways. [4]

The reaction proceeds by the ATP-dependent phosphorylation of UTP on the 4-oxygen atom, making the 4-carbon electrophilic and vulnerable to reaction with ammonia. [5] The source of the amino group in CTP is glutamine, which is hydrolysed in a glutamine amidotransferase domain to produce ammonia. This is then channeled through the interior of the enzyme to the synthetase domain. [6] [7] Here, ammonia reacts with the intermediate 4-phosphoryl UTP. [8]

Ctp synthase mechanism.jpg

Isozymes

Two isozymes with CTP synthase activity exist in humans, encoded by the following genes:

Structure

Dimeric form of CTP synthase from Sulfolobus solfataricus (PDB code: 3NVA). Chain A is depicted in blue and Chain B in green. CTP synthase dimer.jpg
Dimeric form of CTP synthase from Sulfolobus solfataricus (PDB code: 3NVA). Chain A is depicted in blue and Chain B in green.

Active CTP synthase exists as a homotetrameric enzyme. At low enzyme concentrations and in the absence of ATP and UTP, CTP synthase exists as inactive monomer. As enzyme concentration increases, it polymerizes first to a dimer (such as the form shown to the left) and, in the presence of ATP and UTP, forms a tetramer. [5] [9]

The enzyme contains two major domains, responsible for the aminotransferase and synthase activity, respectively. The amidotransferase domains are located away from the tetramer interfaces and are not affected by the oligomeric state. The ATP-binding site and CTP-binding site in the synthase domain are located at the tetramer interface. It is for this reason that ATP and UTP are required for tetramerization. [10]

Regulation

CTP synthase is precisely regulated by the intracellular concentrations of CTP and UTP, and both hCTPS1 and hCTPS2 have been seen to be maximally active at physiological concentrations of ATP, GTP, and glutamine. [11]

The activity of human CTPS1 isozyme has been demonstrated to be inhibited by phosphorylation. [12] One major example of this is phosphorylation of the Ser-571 residue by glycogen synthase kinase 3 (GSK3) in response to low serum conditions. [13] Additionally, Ser568 has been seen to be phosphorylated by casein kinase 1, inhibiting CTP synthase activity. [11]

CTP is also subject to various forms of allosteric regulation. GTP acts as an allosteric activator that strongly promotes the hydrolysis of glutamine, but is also inhibiting to glutamine-dependent CTP formation at high concentrations. [14] This acts to balance the relative amounts of purine and pyrimidine nucleotides. The reaction product CTP also serves as an allosteric inhibitor. The triphosphate binding site overlaps with that of UTP, but the nucleoside moiety of CTP binds in an alternative pocket opposite the binding site for UTP. [15]

CTP synthase levels have been shown to be dependent on levels of the transcription factor Myc. In turn, CTP synthase activity is required for Myc related phenotypes. [16]

The glutamine analog DON has also been seen to act as an irreversible inhibitor, and has been used as an anti-cancer agent. [17]

Filaments

CTP synthase has been reported to form filaments in several different organisms. These include bacteria ( C. crescentus ), [18] yeast ( S. cerevisiae ), [19] fruit flies ( D. melanogaster ) [20] and human cells. [21] These filamentous structures have been referred to as cytoplasmic rods and rings, [22] cytoophidia (from the Greek "cyto" meaning cell and "ophidium" meaning serpent, due to the structures morphology) or simply CTP synthase filaments. It has been shown that filamentation downregulates or upregulates CTP synthase activity depending on the species. [23] [24] [25] [26] [27] In Drosophila, only one of the CTP synthase isoform forms the filament. [28] Since the discovery of this novel mode of enzyme regulation in CTP synthase, multiple other enzymes have been shown to exhibit similar characteristics, suggesting that this is an important and well conserved strategy for enzymatic regulation. [29] CTP synthase remains a model enzyme for the study of filament formation.

Clinical significance

Upregulated CTP synthase activity has been widely seen in human and rodent tumors. [30] Evidence from fly models [16] and human cancer cells [31] suggests that Myc-dependent cell growth may be more susceptible to suppression of CTP-synthase activity.

Mutations in the CTP synthase have been seen to confer resistance to cytotoxic drugs such as cytosine arabinoside (ara-C) in a Chinese hamster ovary (CHO) cell model of leukemia though such mutations were not found in human patients with ara-C resistance. [32]

See also

Related Research Articles

<span class="mw-page-title-main">Nucleotide</span> Biological molecules that form the building blocks of nucleic acids

Nucleotides are organic molecules composed of a nitrogenous base, a pentose sugar and a phosphate. They serve as monomeric units of the nucleic acid polymers – deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), both of which are essential biomolecules within all life-forms on Earth. Nucleotides are obtained in the diet and are also synthesized from common nutrients by the liver.

<span class="mw-page-title-main">Aspartate carbamoyltransferase</span> Protein family

Aspartate carbamoyltransferase catalyzes the first step in the pyrimidine biosynthetic pathway.

<span class="mw-page-title-main">Uridine triphosphate</span> Chemical compound

Uridine-5′-triphosphate (UTP) is a pyrimidine nucleoside triphosphate, consisting of the organic base uracil linked to the 1′ carbon of the ribose sugar, and esterified with tri-phosphoric acid at the 5′ position. Its main role is as substrate for the synthesis of RNA during transcription. UTP is the precursor for the production of CTP via CTP synthetase. UTP can be biosynthesized from UDP by Nucleoside Diphosphate Kinase after using the phosphate group from ATP. UDP + ATP ⇌ UTP + ADP; both UTP and ATP are energetically equal.

<span class="mw-page-title-main">Ribonucleotide</span> Nucleotide containing ribose as its pentose component

In biochemistry, a ribonucleotide is a nucleotide containing ribose as its pentose component. It is considered a molecular precursor of nucleic acids. Nucleotides are the basic building blocks of DNA and RNA. Ribonucleotides themselves are basic monomeric building blocks for RNA. Deoxyribonucleotides, formed by reducing ribonucleotides with the enzyme ribonucleotide reductase (RNR), are essential building blocks for DNA. There are several differences between DNA deoxyribonucleotides and RNA ribonucleotides. Successive nucleotides are linked together via phosphodiester bonds.

A nucleoside triphosphate is a nucleoside containing a nitrogenous base bound to a 5-carbon sugar, with three phosphate groups bound to the sugar. They are the molecular precursors of both DNA and RNA, which are chains of nucleotides made through the processes of DNA replication and transcription. Nucleoside triphosphates also serve as a source of energy for cellular reactions and are involved in signalling pathways.

In molecular biology, biosynthesis is a multi-step, enzyme-catalyzed process where substrates are converted into more complex products in living organisms. In biosynthesis, simple compounds are modified, converted into other compounds, or joined to form macromolecules. This process often consists of metabolic pathways. Some of these biosynthetic pathways are located within a single cellular organelle, while others involve enzymes that are located within multiple cellular organelles. Examples of these biosynthetic pathways include the production of lipid membrane components and nucleotides. Biosynthesis is usually synonymous with anabolism.

<span class="mw-page-title-main">Nucleoside-diphosphate kinase</span>

Nucleoside-diphosphate kinases are enzymes that catalyze the exchange of terminal phosphate between different nucleoside diphosphates (NDP) and triphosphates (NTP) in a reversible manner to produce nucleotide triphosphates. Many NDP serve as acceptor while NTP are donors of phosphate group. The general reaction via ping-pong mechanism is as follows: XDP + YTP ←→ XTP + YDP. NDPK activities maintain an equilibrium between the concentrations of different nucleoside triphosphates such as, for example, when guanosine triphosphate (GTP) produced in the citric acid (Krebs) cycle is converted to adenosine triphosphate (ATP). Other activities include cell proliferation, differentiation and development, signal transduction, G protein-coupled receptor, endocytosis, and gene expression.

<span class="mw-page-title-main">Glutamine synthetase</span> Class of enzymes

Glutamine synthetase (GS) is an enzyme that plays an essential role in the metabolism of nitrogen by catalyzing the condensation of glutamate and ammonia to form glutamine:

<span class="mw-page-title-main">Argininosuccinate synthase</span> Enzyme

Argininosuccinate synthase or synthetase is an enzyme that catalyzes the synthesis of argininosuccinate from citrulline and aspartate. In humans, argininosuccinate synthase is encoded by the ASS gene located on chromosome 9.

<span class="mw-page-title-main">Cytidine triphosphate</span> Chemical compound

Cytidine triphosphate (CTP) is a pyrimidine nucleoside triphosphate. CTP, much like ATP, consists of a ribose sugar, and three phosphate groups. The major difference between the two molecules is the base used, which in CTP is cytosine.

<span class="mw-page-title-main">Nucleic acid metabolism</span> Process

Nucleic acid metabolism is a collective term that refers to the variety of chemical reactions by which nucleic acids are either synthesized or degraded. Nucleic acids are polymers made up of a variety of monomers called nucleotides. Nucleotide synthesis is an anabolic mechanism generally involving the chemical reaction of phosphate, pentose sugar, and a nitrogenous base. Degradation of nucleic acids is a catabolic reaction and the resulting parts of the nucleotides or nucleobases can be salvaged to recreate new nucleotides. Both synthesis and degradation reactions require multiple enzymes to facilitate the event. Defects or deficiencies in these enzymes can lead to a variety of diseases.

<span class="mw-page-title-main">CAD protein</span> Protein-coding gene in the species Homo sapiens

CAD protein is a trifunctional multi-domain enzyme involved in the first three steps of pyrimidine biosynthesis. De-novo synthesis starts with cytosolic carbamoylphosphate synthetase II which uses glutamine, carbon dioxide and ATP. This enzyme is inhibited by uridine triphosphate.

<span class="mw-page-title-main">Carbamoyl phosphate synthetase</span> Class of enzymes

Carbamoyl phosphate synthetase catalyzes the ATP-dependent synthesis of carbamoyl phosphate from glutamine or ammonia and bicarbonate. This enzyme catalyzes the reaction of ATP and bicarbonate to produce carboxy phosphate and ADP. Carboxy phosphate reacts with ammonia to give carbamic acid. In turn, carbamic acid reacts with a second ATP to give carbamoyl phosphate plus ADP.

Carbamoyl phosphate synthetase (glutamine-hydrolysing) is an enzyme that catalyzes the reactions that produce carbamoyl phosphate in the cytosol. Its systemic name is hydrogen-carbonate:L-glutamine amido-ligase .

<span class="mw-page-title-main">Orotate phosphoribosyltransferase</span>

Orotate phosphoribosyltransferase (OPRTase) or orotic acid phosphoribosyltransferase is an enzyme involved in pyrimidine biosynthesis. It catalyzes the formation of orotidine 5'-monophosphate (OMP) from orotate and phosphoribosyl pyrophosphate. In yeast and bacteria, orotate phosphoribosyltransferase is an independent enzyme with a unique gene coding for the protein, whereas in mammals and other multicellular organisms, the catalytic function is carried out by a domain of the bifunctional enzyme UMP synthase (UMPS).

<span class="mw-page-title-main">Ribose-phosphate diphosphokinase</span> Class of enzymes

Ribose-phosphate diphosphokinase is an enzyme that converts ribose 5-phosphate into phosphoribosyl pyrophosphate (PRPP). It is classified under EC 2.7.6.1.

Phosphatidate cytidylyltransferase (CDS) is the enzyme that catalyzes the synthesis of CDP-diacylglycerol from cytidine triphosphate and phosphatidate.

<span class="mw-page-title-main">UCK2</span> Protein-coding gene in the species Homo sapiens

Uridine-cytidine kinase 2 (UCK2) is an enzyme that in humans is encoded by the UCK2 gene.

<span class="mw-page-title-main">CTPS2</span> Protein-coding gene in humans

CTP synthase 2 is an enzyme that in humans is encoded by the CTPS2 gene.

<span class="mw-page-title-main">CTP synthase 1</span> Protein-coding gene in the species Homo sapiens

CTP synthase 1 is an enzyme that is encoded by the CTPS1 gene in humans. CTP synthase 1 is an enzyme in the de novo pyrimidine synthesis pathway that catalyses the conversion of uridine triphosphate (UTP) to cytidine triphosphate (CTP). CTP is a key building block for the production of DNA, RNA and some phospholipids.

References

  1. Lieberman I (October 1956). "Enzymatic amination of uridine triphosphate to cytidine triphosphate". The Journal of Biological Chemistry. 222 (2): 765–775. doi: 10.1016/S0021-9258(20)89934-7 . PMID   13367044.
  2. Long CW, Levitzki A, Koshland DE (January 1970). "The subunit structure and subunit interactions of cytidine triphosphate synthetase". The Journal of Biological Chemistry. 245 (1): 80–87. doi: 10.1016/S0021-9258(18)63424-6 . PMID   5411547.
  3. Koshland DE, Levitzki A (1974). "CTP Synthetase and Related Enzymes". In Boyer PD (ed.). The Enzymes (3rd ed.). New York: Academic Press. pp. 539–59. ISBN   978-0-12-122710-4.
  4. van Kuilenburg AB, Meinsma R, Vreken P, Waterham HR, van Gennip AH (2000). "Isoforms of human CTP synthetase". Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology. Vol. 486. pp. 257–261. doi:10.1007/0-306-46843-3_50. ISBN   978-0-306-46515-4. PMID   11783495.
  5. 1 2 von der Saal W, Anderson PM, Villafranca JJ (December 1985). "Mechanistic investigations of Escherichia coli cytidine-5'-triphosphate synthetase. Detection of an intermediate by positional isotope exchange experiments". The Journal of Biological Chemistry. 260 (28): 14993–14997. doi: 10.1016/S0021-9258(18)95692-9 . PMID   2933396.
  6. Levitzki A, Koshland DE (August 1971). "Cytidine triphosphate synthetase. Covalent intermediates and mechanisms of action". Biochemistry. 10 (18): 3365–3371. doi:10.1021/bi00794a008. PMID   4940761.
  7. Endrizzi JA, Kim H, Anderson PM, Baldwin EP (June 2004). "Crystal structure of Escherichia coli cytidine triphosphate synthetase, a nucleotide-regulated glutamine amidotransferase/ATP-dependent amidoligase fusion protein and homologue of anticancer and antiparasitic drug targets". Biochemistry. 43 (21): 6447–6463. doi:10.1021/bi0496945. PMC   2891762 . PMID   15157079.
  8. Lewis DA, Villafranca JJ (October 1989). "Investigation of the mechanism of CTP synthetase using rapid quench and isotope partitioning methods". Biochemistry. 28 (21): 8454–8459. doi:10.1021/bi00447a027. PMID   2532543.
  9. Anderson PM (June 1983). "CTP synthetase from Escherichia coli: an improved purification procedure and characterization of hysteretic and enzyme concentration effects on kinetic properties". Biochemistry. 22 (13): 3285–3292. doi:10.1021/bi00282a038. PMID   6349684.
  10. Lauritsen I, Willemoës M, Jensen KF, Johansson E, Harris P (February 2011). "Structure of the dimeric form of CTP synthase from Sulfolobus solfataricus". Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 67 (Pt 2): 201–208. doi:10.1107/S1744309110052334. PMC   3034608 . PMID   21301086.
  11. 1 2 Kassel KM, Higgins MJ, Hines M, Graves LM (October 2010). "Regulation of human cytidine triphosphate synthetase 2 by phosphorylation". The Journal of Biological Chemistry. 285 (44): 33727–33736. doi: 10.1074/jbc.M110.178566 . PMC   2962471 . PMID   20739275.
  12. Carman GM, Kersting MC (February 2004). "Phospholipid synthesis in yeast: regulation by phosphorylation". Biochemistry and Cell Biology. 82 (1): 62–70. doi:10.1139/o03-064. PMID   15052328.
  13. Higgins MJ, Graves PR, Graves LM (October 2007). "Regulation of human cytidine triphosphate synthetase 1 by glycogen synthase kinase 3". The Journal of Biological Chemistry. 282 (40): 29493–29503. doi: 10.1074/jbc.M703948200 . PMID   17681942.
  14. Lunn FA, MacDonnell JE, Bearne SL (January 2008). "Structural requirements for the activation of Escherichia coli CTP synthase by the allosteric effector GTP are stringent, but requirements for inhibition are lax". The Journal of Biological Chemistry. 283 (4): 2010–2020. doi: 10.1074/jbc.M707803200 . PMID   18003612.
  15. Endrizzi JA, Kim H, Anderson PM, Baldwin EP (October 2005). "Mechanisms of product feedback regulation and drug resistance in cytidine triphosphate synthetases from the structure of a CTP-inhibited complex". Biochemistry. 44 (41): 13491–13499. doi:10.1021/bi051282o. PMC   2891682 . PMID   16216072.
  16. 1 2 Aughey GN, Grice SJ, Liu JL (February 2016). "The Interplay between Myc and CTP Synthase in Drosophila". PLOS Genetics. 12 (2): e1005867. doi: 10.1371/journal.pgen.1005867 . PMC   4759343 . PMID   26889675.
  17. Ahluwalia GS, Grem JL, Hao Z, Cooney DA (1990). "Metabolism and action of amino acid analog anti-cancer agents". Pharmacology & Therapeutics. 46 (2): 243–271. doi:10.1016/0163-7258(90)90094-I. PMID   2108451.
  18. Ingerson-Mahar M, Briegel A, Werner JN, Jensen GJ, Gitai Z (August 2010). "The metabolic enzyme CTP synthase forms cytoskeletal filaments". Nature Cell Biology. 12 (8): 739–746. doi:10.1038/ncb2087. PMC   3210567 . PMID   20639870.
  19. Noree C, Sato BK, Broyer RM, Wilhelm JE (August 2010). "Identification of novel filament-forming proteins in Saccharomyces cerevisiae and Drosophila melanogaster". The Journal of Cell Biology. 190 (4): 541–551. doi:10.1083/jcb.201003001. PMC   2928026 . PMID   20713603.
  20. Liu JL (May 2010). "Intracellular compartmentation of CTP synthase in Drosophila". Journal of Genetics and Genomics = Yi Chuan Xue Bao. 37 (5): 281–296. doi:10.1016/S1673-8527(09)60046-1. PMID   20513629. S2CID   206173864.
  21. Chen K, Zhang J, Tastan ÖY, Deussen ZA, Siswick MY, Liu JL (September 2011). "Glutamine analogs promote cytoophidium assembly in human and Drosophila cells". Journal of Genetics and Genomics = Yi Chuan Xue Bao. 38 (9): 391–402. doi:10.1016/j.jgg.2011.08.004. PMID   21930098.
  22. Carcamo WC, Satoh M, Kasahara H, Terada N, Hamazaki T, Chan JY, et al. (2011). "Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells". PLOS ONE. 6 (12): e29690. Bibcode:2011PLoSO...629690C. doi: 10.1371/journal.pone.0029690 . PMC   3248424 . PMID   22220215.
  23. Lynch EM, Hicks DR, Shepherd M, Endrizzi JA, Maker A, Hansen JM, et al. (June 2017). "Human CTP synthase filament structure reveals the active enzyme conformation". Nature Structural & Molecular Biology. 24 (6): 507–514. doi:10.1038/nsmb.3407. PMC   5472220 . PMID   28459447.
  24. Barry RM, Bitbol AF, Lorestani A, Charles EJ, Habrian CH, Hansen JM, et al. (July 2014). "Large-scale filament formation inhibits the activity of CTP synthetase". eLife. 3: e03638. doi: 10.7554/eLife.03638 . PMC   4126345 . PMID   25030911.
  25. Aughey GN, Grice SJ, Shen QJ, Xu Y, Chang CC, Azzam G, et al. (October 2014). "Nucleotide synthesis is regulated by cytoophidium formation during neurodevelopment and adaptive metabolism". Biology Open. 3 (11): 1045–1056. doi:10.1242/bio.201410165. PMC   4232762 . PMID   25326513.
  26. Noree C, Monfort E, Shiau AK, Wilhelm JE (August 2014). "Common regulatory control of CTP synthase enzyme activity and filament formation". Molecular Biology of the Cell. 25 (15): 2282–2290. doi:10.1091/mbc.E14-04-0912. PMC   4116302 . PMID   24920825.
  27. Barry RM, Gitai Z (December 2011). "Self-assembling enzymes and the origins of the cytoskeleton". Current Opinion in Microbiology. 14 (6): 704–711. doi:10.1016/j.mib.2011.09.015. PMC   3234109 . PMID   22014508.
  28. Azzam G, Liu JL (February 2013). "Only one isoform of Drosophila melanogaster CTP synthase forms the cytoophidium". PLOS Genetics. 9 (2): e1003256. doi: 10.1371/journal.pgen.1003256 . PMC   3573105 . PMID   23459760.
  29. Aughey GN, Liu JL (2015). "Metabolic regulation via enzyme filamentation". Critical Reviews in Biochemistry and Molecular Biology. 51 (4): 282–293. doi:10.3109/10409238.2016.1172555. PMC   4915340 . PMID   27098510.
  30. Kizaki H, Williams JC, Morris HP, Weber G (November 1980). "Increased cytidine 5'-triphosphate synthetase activity in rat and human tumors". Cancer Research. 40 (11): 3921–3927. PMID   7471043.
  31. Sun Z, Zhang Z, Wang QQ, Liu JL (March 2022). "Combined Inactivation of CTPS1 and ATR Is Synthetically Lethal to MYC-Overexpressing Cancer Cells". Cancer Research. 82 (6): 1013–1024. doi:10.1158/0008-5472.can-21-1707. PMC   9359733 . PMID   35022212.
  32. Whelan J, Smith T, Phear G, Rohatiner A, Lister A, Meuth M (February 1994). "Resistance to cytosine arabinoside in acute leukemia: the significance of mutations in CTP synthetase". Leukemia. 8 (2): 264–265. PMID   8309250.

Further reading